Despite the introduction of new anti-seizure medications in recent years, approximately one-
third of the epileptic population continues to experience seizures. Recently, the anti-obesity …

Despite progress in the development of anti‐seizure medications (ASMs), one third of
people with epilepsy have drug‐resistant epilepsy (DRE). The working definition of DRE …

Cancer is one of the leading causes of death in both developed and developing countries.
Due to its heterogenous nature, it occurs in various regions of the body and often goes …

Epilepsy comorbidities and anti‑epileptic drugs (AEDs) are currently the main limitations of
epilepsy treatment. Semaglutide is a glucagon like peptide‑1 analogue that has entered the …

With the development of computer technology, computer-aided medical diagnosis based on
signal processing is trending up. In recent years, the detection of epilepsy …

Drug-resistant epilepsy is associated with poor health outcomes and increased economic
burden. In the last three decades, various new antiseizure medications have been …

Epilepsy (EP) is a complex brain disorder showing a lot of unknows reasons. Recent studies
showed that gut microbiota can influence epilepsy via the brain–gut axis. Nevertheless, the …

In the central nervous system (CNS), the effective delivery of pharmacological agents
remains limited by several brain barriers [ie, the blood–brain barrier (BBB), blood …

Tandem of P domains in a weak inwardly rectifying K+ channel (TWIK)-related acid sensitive
K+-1 channel (TASK-1) is an outwardly rectifying K+ channel that acts in response to …

La epilepsia es una de las enfermedades neurológicas más antiguas y reconocidas del
mundo. En las últimas dos décadas se han utilizado clínicamente varios fármacos …